MORGAN ADAM purchased 25.3% of their position (1.77M shares) of HERON THERAPEUTICS, INC. /DE/ on the open market
Open‑market purchase worth $2.65M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/12/2025ACC: 0000921895-25-002160
+1.84M
Net shares
Net buyer
$2.65M
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
1.84M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1.77M
Price / share
$1.50
Trade value
$2.65M
% of position
25.3%
8/8/2025
6.99M→8.75M
Total
Net shares
+1.77M
Net value
$2.65M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/8/2025 | P · Purchase | +1.77M | $1.50 | $2.65M | 25.3% | 6.99M | 8.75M |
| Total | +1.77M | $2.65M | ||||||
Derivative Transactions1
Series A Convertible Preferred Stock
Indirect
Converts to
Common Stock
700.12K shares
Shares
+70.01K
Strike price
1.50
Held after
70.01K
Exercisable
—
8/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Indirect | Common Stock700.12K shares | 8/8/2025 | P · Purchase | +70.01K | 1.50 | — | 70.01K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned69.78K
Total
69.78K direct69.78K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 69.78K | Direct |
| Total | 69.78K | 69.78K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported